Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2025-12-25 @ 12:37 AM
NCT ID:
NCT05805267
Eligibility Criteria:
Inclusion Criteria:
* 1)≥18;
* 2\) advanced non-small cell lung cancer confirmed by histopathology;
* 3\) Patients with NSCLC who have previously or are taking gefitinib (first-line therapy) or osimertinib (post-TKI resistance) or crizotinib monotherapy, and the response to treatment can be assessed;
* 4\) Have sufficient FFPE tissue samples within 5 years: 5 large specimens/case; There were 10 puncture specimens/case
Exclusion Criteria:
* 1\) Combination therapy with chemotherapy/radiotherapy/other targeted drugs/immunotherapy drugs;
* 2)Maintenance therapy if the disease does not progress after treatment with other antitumor methods
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05805267
Study Brief:
Protocol Section:
NCT05805267